⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13861306 | 1.00 | — | — | |
| SCHEMBL5909124 | 1.00 | CHRNB2 (0.30) | — | |
| Bromide SCHEMBL6847337 | 0.96 | — | — | |
| SCHEMBL31483450 | 0.86 | — | — | |
| SCHEMBL13866433 | 0.84 | — | — | |
| SCHEMBL14671382 | 0.84 | — | — | |
| SCHEMBL22276138 | 0.83 | — | — | |
| SCHEMBL22536323 | 0.83 | — | — | |
| SCHEMBL13601390 | 0.81 | — | — | |
| SCHEMBL12354649 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858933-B2 | Tricyclic Janus kinase 1 inhibitors, and compositions and methods thereof | LYNK PHARMACEUTICALS CO. LTD. (CN) | 2024-01-02 | — | — | US | disclosed |